Calreticulin mutation specific CAL2 immunohistochemistry accurately identifies rare calreticulin mutations in myeloproliferative neoplasms.

Adolescent Adult Aged Aged, 80 and over Calreticulin / genetics Child Child, Preschool DNA Mutational Analysis Female Humans Immunohistochemistry Male Middle Aged Mutation Primary Myelofibrosis / genetics Thrombocythemia, Essential / genetics Young Adult
CAL2 immunohistochemistry Myeloproliferative neoplasms calreticulin mutation mutation load

Journal

Pathology
ISSN: 1465-3931
Titre abrégé: Pathology
Pays: England
ID NLM: 0175411

Informations de publication

Date de publication:
Apr 2019
Historique:
received: 21 08 2018
revised: 31 10 2018
accepted: 08 11 2018
pubmed: 5 1 2019
medline: 30 5 2019
entrez: 5 1 2019
Statut: ppublish

Résumé

Mutations of the multifunctional protein calreticulin (CALR) are recognised as one of the main driver alterations involved in the pathogenesis of Philadelphia negative myeloproliferative neoplasms (Ph

Identifiants

DOI: 10.1016/j.pathol.2018.11.007 PMID: 30606612
pubmed: 30606612
pii: S0031-3025(18)30385-4
doi: 10.1016/j.pathol.2018.11.007
pii:
doi:

Substances chimiques

Calreticulin 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

301-307

Informations de copyright

Copyright © 2018 Royal College of Pathologists of Australasia. Published by Elsevier B.V. All rights reserved.

Auteurs

Réka Mózes (R)

MTA-SE Momentum Molecular Oncohematology Research Group, Semmelweis University, 1st Department of Pathology and Experimental Cancer Research, Budapest, Hungary.

Ambrus Gángó (A)

MTA-SE Momentum Molecular Oncohematology Research Group, Semmelweis University, 1st Department of Pathology and Experimental Cancer Research, Budapest, Hungary.

Adrienn Sulák (A)

2nd Department of Internal Medicine and Cardiology Center, University of Szeged, Szeged, Hungary.

Livia Vida (L)

Department of Pathology, University of Pécs, Pécs, Hungary.

Lilla Reiniger (L)

1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary.

Botond Timár (B)

MTA-SE Momentum Molecular Oncohematology Research Group, Semmelweis University, 1st Department of Pathology and Experimental Cancer Research, Budapest, Hungary.

Tibor Krenács (T)

1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary.

Hussain Alizadeh (H)

1st Department of Internal Medicine, Hematology Division, University of Pécs, Pécs, Hungary.

Tamás Masszi (T)

3rd Department of Internal Medicine, Semmelweis University, Budapest, Hungary.

Júlia Gaál-Weisinger (J)

1st Department of Internal Medicine, Semmelweis University, Budapest, Hungary.

Judit Demeter (J)

1st Department of Internal Medicine, Semmelweis University, Budapest, Hungary.

Judit Csomor (J)

1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary.

András Matolcsy (A)

MTA-SE Momentum Molecular Oncohematology Research Group, Semmelweis University, 1st Department of Pathology and Experimental Cancer Research, Budapest, Hungary.

Béla Kajtár (B)

Department of Pathology, University of Pécs, Pécs, Hungary. Electronic address: kajtar.bela@pte.hu.

Csaba Bödör (C)

MTA-SE Momentum Molecular Oncohematology Research Group, Semmelweis University, 1st Department of Pathology and Experimental Cancer Research, Budapest, Hungary. Electronic address: bodor.csaba1@med.semmelweis-univ.hu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Personnes › Tranches d'âge › Adolescent › Calreticulin mutation specific CAL2...
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Calreticulin mutation specific CAL2...
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Sujet âgé › Calreticulin mutation specific CAL2...
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Sujet âgé › Sujet âgé de 80 ans ou plus › Calreticulin mutation specific CAL2...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Lectines › Calréticuline › Calreticulin mutation specific CAL2...
questionsmedicales.fr › Personnes › Tranches d'âge › Enfant › Calreticulin mutation specific CAL2...
questionsmedicales.fr › Personnes › Tranches d'âge › Enfant › Enfant d'âge préscolaire › Calreticulin mutation specific CAL2...
questionsmedicales.fr › Techniques d'investigation › Techniques génétiques › Analyse de séquence › Analyse de séquence d'ADN › Analyse de mutations d'ADN › Calreticulin mutation specific CAL2...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Calreticulin mutation specific CAL2...
questionsmedicales.fr › Disciplines des sciences naturelles › Chimie › Biochimie › Immunohistochimie › Calreticulin mutation specific CAL2...
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Adulte d'âge moyen › Calreticulin mutation specific CAL2...
questionsmedicales.fr › Phénomènes génétiques › Variation génétique › Mutation › Calreticulin mutation specific CAL2...
questionsmedicales.fr › Hémopathies et maladies lymphatiques › Hémopathies › Maladies de la moelle osseuse › Syndromes myéloprolifératifs › Myélofibrose primitive › Calreticulin mutation specific CAL2...
questionsmedicales.fr › Hémopathies et maladies lymphatiques › Hémopathies › Troubles hémorragiques › Thrombocytémie essentielle › Calreticulin mutation specific CAL2...
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Jeune adulte › Calreticulin mutation specific CAL2...